Advertisement

Current Heart Failure Reports

, Volume 15, Issue 3, pp 156–160 | Cite as

Optimizing Cardiac Resynchronization Therapy: an Update on New Insights and Advancements

  • Adam Grimaldi
  • Eiran Z. Gorodeski
  • John Rickard
Pharmacologic Therapy (W.H.W. Tang, Section Editor)
  • 237 Downloads
Part of the following topical collections:
  1. Topical Collection on Pharmacologic Therapy

Abstract

Purpose of Review

This review focuses on the current advancements in optimizing patient response to cardiac resynchronization therapy (CRT).

Recent Findings

It has been well known that not every patient will derive benefit from CRT, and of those that do, there are varying levels of response. Optimizing CRT begins well before device implant and involves appropriate patient selection and an understanding of the underlying substrate. After implant, there are different CRT device programming options that can be enabled to help overcome barriers as to why a patient may not respond.

Summary

Given the multifaceted components of optimizing CRT and the complex patient population, multi-subspecialty clinics have been developed bringing together specialists in heart failure, electrophysiology, and imaging. Data as to whether this results in better response rates and outcomes shows promise.

Keywords

Heart failure Cardiac resynchronization therapy CRT optimization CRT optimization clinic Electrophysiology EP device management 

Notes

Compliance with Ethical Standards

Conflict of Interest

Adam Grimaldi and Eiran Z. Gorodeski declare no conflicts of interest. John Rickard reports personal fees from Medtronic and personal fees from Boston scientific, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 2002;39(2):194–201.CrossRefPubMedGoogle Scholar
  2. 2.
    Rickard J, Cheng A, Spragg D, Bansal S, Niebauer M, Baranowski B, et al. Durability of survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of “non-responders”. Heart Rhythm. 2014;11(3):412–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Rickard J, Michtalik H, Sharma R, Berger Z, Iyoha E, Green AR, et al. Predictors of response to cardiac resynchronization therapy: a systematic review. Int J Cardiol. 2016;225:345–52.CrossRefPubMedGoogle Scholar
  4. 4.
    Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol. 2006;219:20–6.CrossRefGoogle Scholar
  5. 5.
    Rickard J, Jackson G, Spragg DD, Cronin EM, Baranowski B, Tang WHW, et al. QRS prolongation induced by cardiac resynchronization therapy correlates with deterioration in left ventricular function. Heart Rhythm. 2012;9(10):1674–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Rickard J, Kumbhani DJ, Popovic Z, Verhaert D, Manne M, Sraow D, et al. Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm. 2010;7(7):885–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Curtis AB, Worley SJ, Chung ES, et al. Improvement in Clin outcomes with biventricular versus right ventricular pacing: the BLOCK HF study. J Am Coll Cardiol. 2016;18:2148–57.CrossRefGoogle Scholar
  8. 8.
    Rickard J, Kumbhani DJ, Gorodeski EZ, Baranowski B, Wazni O, Martin DO, et al. Cardiac resynchronization therapy in non-left bundle branch block morphologies. Pacing Clin Electrophysiol. 2010;33(5):590–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Wokhlu A, Rea RF, Asirvatham SJ, Webster T, Brooke K, Hodge DO, et al. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival. Heart Rhythm. 2009;6:1439–47.CrossRefPubMedGoogle Scholar
  10. 10.
    Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, et al. Effectiveness of cardiac Resyncrhonization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT). Circulation. 2011;123:1061–72.CrossRefPubMedGoogle Scholar
  11. 11.
    Rickard J, Bassiouny M, Cronin EM, Martin DO, Varma N, Niebauer MJ, et al. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology. Am J Cardiol. 2011;108(11):1576–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Fantoni C, Kawabata M, Massaro R, et al. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping system. J Cardiovasc Electrophysiol. 2005;16(2):112–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Varma N. Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction. Am J Cardiol. 2009;103(11):1578–85.CrossRefPubMedGoogle Scholar
  14. 14.
    Nikoo MH, Aslani A, Jorat MV. LBBB: state-of-the-art criteria. Int Cardiovasc Res J. 2013;7(2):39–40.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association electrocardiography and arrhythmias committee, council on clinical cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):976–81.CrossRefPubMedGoogle Scholar
  16. 16.
    Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol. 2011;107(6):927–34.CrossRefPubMedGoogle Scholar
  17. 17.
    Migliore F, Baritussio A, Stabile G, Reggiani A, D’Onofrio A, Palmisano P, et al. Prevalence of true left bundle branch block in current practice of cardiac resynchronization therapy implantation. J Cardiovasc Med. 2016;17(7):462–8.CrossRefGoogle Scholar
  18. 18.
    Epstein AE, DiMarco JP, Ellenbogen KA, American College of Cardiology Foundation; American Heart Association task force on practice guidelines, Heart Rhythm Society, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device –based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61:6–75.CrossRefGoogle Scholar
  19. 19.
    Kim J, Shin MS, Hwang SY, Park E, Lim YH, Shim JL, et al. Memory loss and decreased executive function are associated with limited functional capacity in patients with heart failure compared to patients with other medical conditions. Heart Lung. 2018;47(1):61–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Verbrugge FH, Dupont M, Rivero-Ayerza M, de Vusser P, van Herendael H, Vercammen J, et al. Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling. J Card Fail. 2012;18(11):845–53.CrossRefPubMedGoogle Scholar
  21. 21.
    Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–66.CrossRefPubMedGoogle Scholar
  22. 22.
    Hayes DL, Boehmer JP, Day JD, Gilliam FR III, Heidenreich PA, Seth M, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8(9):1469–75.CrossRefPubMedGoogle Scholar
  23. 23.
    Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT). Circulation. 2011;123(11):1159–66.CrossRefPubMedGoogle Scholar
  24. 24.
    Wilton SB, Shibata MA, Sondergaard R, Cowan K, Semeniuk L, Exner DV. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol. 2008;23(3):219–27.CrossRefPubMedGoogle Scholar
  25. 25.
    Gold MR, Birdersdotter-Green U, Singh JP, et al. The relationship between ventricular electrical delay and left ventricular remodeling with cardiac resynchronization therapy. Eur Heart J. 2011;32(20):2516–24.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual chamber and VVI implantable defibrillator trial investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA. 2002;288(24):3115–23.CrossRefPubMedGoogle Scholar
  27. 27.
    Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, et al. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the biventricular versus left Univentricular pacing with ICD back-up in heart failure patients (B-LEFT HF) trial. Am Heart J. 2010;159(6):1052–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Martin DO, Lemke B, Birnie D, Krum H, Lee KL, Aonuma K, et al. Adaptive CRT study investigators. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012;9(11):1807–14.CrossRefPubMedGoogle Scholar
  29. 29.
    • Tomassoni G, Baker J, Corbisiero R, et al. Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial. Ann Noninvasive Electrocardiol, 2017;22(6).  https://doi.org/10.1111/anec.12448. This study is ongoing and will help to answer wether MPP results in improved CRT response rates.
  30. 30.
    Kamath GS, Cotiga D, Koneru JN, Arshad A, Pierce W, Aziz EF, et al. The utility of 12-lead holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol. 2009;53(12):1050–5.CrossRefPubMedGoogle Scholar
  31. 31.
    • Plummer CJ, Frank CM, Bari Z, et al. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: the CRTee randomized crossover trial. Heart Rhythm. 2017;S1547-5271(17):31240–7. This study shows that with this novel algorithm, there is an increase in effective CRT pacing in patients with AF. More data is needed to see if this means improved response to CRT and clinical outcomes. Google Scholar
  32. 32.
    Ellenbogen KA, Gold MR, Meyer TE, Fernndez Lozano I, Mittal S, Waggoner AD, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122(25):2660–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Boriani G, Muller CP, Seidl KH, et al. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The resynchronization for the HemodYnamic treatment for heart failure management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J. 2006;151(5):1050–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Weiss R, Malik M, Dinerman J, et al. VV optimization in cardiac resynchronization therapy non-responders: RESPONSE-HF trial results. Abstract AB12–5. Denber (CO): HRS. 2010.Google Scholar
  35. 35.
    Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy. J Am Coll Cardiol. 2012;59(17):1509–18.CrossRefPubMedGoogle Scholar
  36. 36.
    Saba S, Marek J, Schwartzman D, Jain S, Adelstein E, White P, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy. Circ Heart Fail. 2013;6(3):427–34.CrossRefPubMedGoogle Scholar
  37. 37.
    Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BL, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53(9):765–73.CrossRefPubMedGoogle Scholar
  38. 38.
    Altman RK, Parks KA, Schlett CL, et al. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J. 2012;17:2181–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Adam Grimaldi
    • 1
  • Eiran Z. Gorodeski
    • 2
  • John Rickard
    • 3
  1. 1.Cardiology FellowshipCleveland Clinic Heart and Vascular InstituteClevelandUSA
  2. 2.Heart FailureCleveland Clinic Heart and Vascular InstituteClevelandUSA
  3. 3.ElectrophysiologyCleveland Clinic Heart and Vascular InstituteClevelandUSA

Personalised recommendations